echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Huahai Q3 announced a 33.3% increase in net profit in the third quarter, with a profit of 542 million yuan in the first three quarters

    Huahai Q3 announced a 33.3% increase in net profit in the third quarter, with a profit of 542 million yuan in the first three quarters

    • Last Update: 2019-10-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On October 30, Huahai pharmaceutical finally released the Q3 report of 2019, which was not as expected The share price fell sharply and the profit rose significantly However, the most striking thing in the report is that the profit growth is impressive From July to September, the net profit growth rate reached 333%, the total profit reached 239 million yuan, an increase rate of 213.96%, and from January to September, the net profit reached 542 million yuan, an increase rate of 98.32% For such a huge increase, Huahai owes to: last year, affected by the Valsartan impurity event, the company has accrued some losses that may be caused by the Valsartan impurity event from January to September last year, and at the same time, the company's profit increases in this period due to factors such as the increase in the price of some products, the increase in technical service income, etc Combined with the announcement on the European Pharmacopoeia adaptability certificate of irbesartan API and losartan potassium API released by Huahai on October 16, the positive effect of European lifting on the sales of Huahai valsartan is that many shareholders are more optimistic about Huahai pharmaceutical What's more, the proportion of profit growth in Europe has just been lifted If the U.S lifting the ban, it will not be a big deal ? Although some valsartan impurity events have a great impact on China Sea in 2018, no matter in reputation or profit, since 2019, the expansion of 4 + 7 has been successful, followed by the lifting of the ban on European APIs, and good news comes one after another We can boldly guess that the annual report of China sea in 2019 will be more brilliant Penicillin statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.